Submitted:
11 July 2024
Posted:
12 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Eligibility Criteria and Sample Size
2.2. Statistical Analysis
3. Results
3.1. Admissions to the pediatric ICU at HCFMB
3.2. Characterization of the Children Who Died
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sociedade Brasileira de Pediatria (SBP). Guidelines for care of individuals with Down syndrome; Department of Genetics: São Paulo, 2020. [Google Scholar]
- National Down Syndrome Society (NDSS). Down syndrome. Available online: https://www.ndss.org/about-down-syndrome/down-syndrome/ (accessed on Nov 1, 2020).
- Malt, E.A.; et al. Health and disease in adults with Down syndrome. Tidsskr. Nor. Laegeforen. 2013, 133(3), 290–294. [Google Scholar] [CrossRef] [PubMed]
- Brazil. Ministério da Saúde. Portaria nº 81 de 20 de janeiro de 2009. Institui, no âmbito do Sistema Único de Saúde (SUS), a Política Nacional de Atenção Integral em Genética Clínica. Brasília: Ministério da Saúde; 2009. Available from: http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2009/GM/GM-81.html. Accessed 6 Apr 2020.
- Whooten, R.; Schmitt, J.; Schwartz, A. Endocrine manifestations of Down syndrome. Curr. Opin. Endocrinol. Diabetes Obes. 2017, 1. [Google Scholar] [CrossRef] [PubMed]
- Murphy, M.; Lempert, M.J.; Epstein, L.B. Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am. J. Med. Genet. 2005, 37 Suppl. S7, 234–237. [Google Scholar] [CrossRef] [PubMed]
- Li, C.; Jin, L.; Bai, Y.; Chen, Q.; Fu, L.; Yang, M.; et al. Genome-Wide Expression Analysis in Down Syndrome: Insight into Immunodeficiency. PLoS ONE 2012, 7(11), e49130. [Google Scholar] [CrossRef] [PubMed]
- Licastro, F.; et al. Derangement of non-specific immunity in Down syndrome subjects: Low leukocyte chemiluminescence activity after phagocytic activation. Am. J. Med. Genet. 2005, 37 Suppl. S7, 242–246. [Google Scholar] [CrossRef] [PubMed]
- Soares, JA.; et al. Distúrbios respiratórios em crianças com síndrome de Down. Arq. Ciênc. Saúde 2004, 11 (4), 230-233.
- Ciotti, M.; et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 2020, 57(6), 365–388. [Google Scholar] [CrossRef] [PubMed]
- Espinosa, J.M. Down syndrome and COVID-19: a perfect storm? Cell Rep. Med. 2020, 1 (2).
- Callea, M.; et al. COVID-19 and Down syndrome. Acta Paediatr. 2020, 109(9), 1901. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. The ICD-10 classification of mental and behavioural disorders; World Health Organization: Geneva, 1993. [Google Scholar]
- DATASUS. Morbidade Hospitalar do SUS por local de internação. Accessed February 2022. Available online: http://tabnet.datasus.gov.br/cgi/sih/nidescr.htm#:~:text=Faixa%20et%C3%A1ria%20do%20paciente%2C%20nas,e%20mais%20e%20idade%20ignorada.
- Fisher, R.A. Statistical methods for research workers. Nig J Paediatr. London: Oliver and Boyd, 1950: 80.
- Joffre, C.; et al. Children with Down syndrome: Clinical course and mortality-associated factors in a French medical paediatric intensive care unit. J. Paediatr. Child Health 2016, 52(6), 595–599. [Google Scholar] [CrossRef] [PubMed]
- Sociedade Brasileira de Cardiologia (SBC). Sobrevida de crianças com Down e defeitos cardíacos congênitos tem aumentado nos últimos 30 anos. [accessed Jul 2023]. SBC. 18 March 2022. Available from: https://www.portal.cardiol.br/post/sobrevida-de-criancas-com-down-e-defeitos-cardiacos-congenitos-tem-aumentado-nos-ultimos-30-anos.
- Lorena SHT. Síndrome de Down: epidemiologia e alterações oftalmológicas. Rev Bras Oftalmol. 2012;71(3):188-190. [CrossRef]
- Tătaru CI, et al. Clinical and therapeutic particularities of congenital cataracts in pediatric patients with Down syndrome. Rom J Ophthalmol. 2020;64(2):168-175.
- Kabylbekova A, et al. Clinical characteristics of congenital and developmental cataract in Kazakhstan. Indian J Ophthalmol. 2022;70(12):4325-4330. [CrossRef]
- Santoro SL, et al. Surgical, medical and developmental outcomes in patients with Down syndrome and cataracts. SAGE Open Med.
- Stoll C, et al. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet. 2015;58(12):674-680. [CrossRef]
- Benhaourech S, et al. Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr. 2016;27(5):287-290. [CrossRef]
- Belo WA, et al. Perfil Clínico-hospitalar De Crianças Com Cardiopatia Congênita. Cad Saúde Colet. 2016;24(2):216-220. [CrossRef]
- Seifert HA, et al. Female gender increases the risk of death during hospitalization for pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2007;133(3):668-675. [CrossRef]
- Cappellesso VR, Aguiar AP. Cardiopatias congênitas em crianças e adolescentes: caracterização clínico-epidemiológica em um hospital infantil de Manaus-AM. Mundo Saúde. 2017;41(2):144-153.4.
- So SA, et al. Hospitalizations of infants and young children with Down syndrome: evidence from inpatient person-records from a statewide administrative database. J Intellect Disabil Res. 2007;51(Pt 12):1030-1038. [CrossRef]
- Costa-Carvalho BT, et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res. 2006;39(12):1587-1592. [CrossRef]
- Kimura T, et al. Utilization and efficacy of palivizumab for children with Down syndrome. Pediatr Int. 2020;62(6):677-682. [CrossRef]
- Luna MS, et al. Expert consensus on palivizumab use for respiratory syncytial virus in developed countries. Paediatr Respir Rev. 2020;33:35-44. [CrossRef]
- Emes D, et al. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey. J Clin Med. 2021;10(21):5125. Available from. [CrossRef]
- Malle L, et al. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease. Genet Med. 2021;23(3):576-580. [CrossRef]
- Leung C, et al. Risk for severe illness and death among pediatric patients with Down syndrome hospitalized for COVID-19, Brazil. Emerg Infect Dis. 2023;29(1):26-35. [CrossRef]
- Benito LAO, et al. Comorbidades e fatores de risco identificados em pessoas que vieram a óbito por Síndrome Respiratória Aguda Grave por Covid-19. Rev Divulg Cient Sena Aires. 2021;10(3):607-623.
- Lopes GK, et al. Estudo epidemiológico das infecções neonatais no Hospital Universitário de Londrina, Estado do Paraná. Acta Sci Health Sci. 2008;30(1):55-63.
- Rodrigues RLF. Infecções no pós-operatório de cirurgia cardíaca em crianças com Síndrome de Down. Dissertação de mestrado. 2013.
- Garrison MM, et al. Risk of death for children with Down syndrome and sepsis. J Pediatr. 2005;147(6):748-752. [CrossRef]
- Mora-Bautista, V.M. Anomalías congénitas del riñón y del tracto urinario en niños con síndrome de Down. Rev Colomb Nefrol. 2018;5(1):54-60.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).